Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells
Author:
Funder
National Natural Science Foundation of China
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference39 articles.
1. One-pot construction of boronate ester based pH-responsive micelle for combined cancer therapy;Chen;Colloids Surfaces B,2016
2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009
3. Interlayer-crosslinked micelle with partially hydrated core showing reduction and pH dual sensitivity for pinpointed intracellular drug release94049408 DaiJ. LinS. ChengD. ZouS. ShuaiX. 10.1002/anie.20110380621898731Angew. Chem. Int. Ed Engl.502011
4. Chemotherapy and target therapy for hepatocellular carcinoma: new advances and challenges;Deng;World J. Hepatol.,2015
5. Poly(β-cyclodextrin)-mediated polylactide-cholesterol stereocomplex micelles for controlled drug delivery;Feng;Chin. J. Polym. Sci.,2017
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Bioengineered DNA-decorated UiO-66-based nanocarriers for combined administration of doxorubicin and sorafenib: Hepatocellular carcinoma treatment and chemotherapy;Alexandria Engineering Journal;2024-01
2. Nanobiomaterials: exploring mechanistic roles in combating microbial infections and cancer;Discover Nano;2023-12-20
3. Reduction‐Responsive Supramolecular Sheets for Selective Regulation of Facultative Anaerobe Agglutination;Advanced Healthcare Materials;2023-05-15
4. Therapeutic applications of nanobiotechnology;Journal of Nanobiotechnology;2023-05-06
5. Co-delivery of doxorubicin/sorafenib by DNA-decorated green ZIF-67-based nanocarriers for chemotherapy and hepatocellular carcinoma treatment;Environmental Research;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3